The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis

Steatohepatitis, Nonalcoholic Clinical Trial

Official title:
The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

Status Completed

Clinical Trial Summary

The aim of the current study is to evaluate the safety and efficay of Montelukast in treatment of patients with fatty liver disease.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Fatty Liver
Non-alcoholic Fatty Liver Disease
Steatohepatitis, Nonalcoholic

Clinical Trial Details

NCT number	NCT04080947
Study type	Interventional
Source	Sadat City University
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	August 1, 2019
Completion date	March 15, 2022

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04861012` - Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt	N/A
Not yet recruiting	`NCT06302049` - Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis	Phase 1/Phase 2
Completed	`NCT04932512` - A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224	Phase 2
Completed	`NCT03915002` - Integrated Approaches for Identifying Molecular Targets in Liver Disease
Recruiting	`NCT04707651` - Formula Diet Treatment for NASH Patients.	N/A
Terminated	`NCT04175392` - Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis	Phase 1/Phase 2
Recruiting	`NCT04785937` - Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients	N/A
Active, not recruiting	`NCT05946330` - Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD).	N/A
Terminated	`NCT04284371` - The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients